Skip to main content
Clinical Trials/IRCT20200708048051N3
IRCT20200708048051N3
Recruiting
Phase 3

Clinical Trial of Evaluation of the effects of intranasal desmopressin on intraoperative blood loss and quality of the surgical field during open rhinoplasty:

Rasht University of Medical Sciences0 sites120 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Rhinoplasty surgery.
Sponsor
Rasht University of Medical Sciences
Enrollment
120
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Rasht University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • All patients 18 to 40 years old who are candidates for rhinoplasty

Exclusion Criteria

  • People with abnormal coagulation tests
  • People with a history of cardiovascular disease
  • Patients with coagulation diseases
  • People taking anticoagulants
  • Patients with brain diseases, hypertension and diabetes
  • Pregnant women
  • History of seizures
  • Consumption of herbal supplements and vitamin E.
  • Corticosteroid users in the last two weeks
  • Consumers of diuretics

Outcomes

Primary Outcomes

Not specified

Similar Trials